Open AccessA COMPLETE REVIEW OF MIGRAINE
Author(s) -
Balaji Ommurugan,
Amita Priya,
Laxminarayana Kurady Bairy
Publication year - 2017
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2017.v10i10.19207
Subject(s) - migraine , medicine , aura , sumatriptan , headaches , migraine with aura , riboflavin , pharmacology , surgery , biochemistry , chemistry , receptor , agonist
Migraine characterized by recurrent headaches present with aura or without aura. Various treatment modalities ranging from 5-hydroxytryptamine 1B/1D agonists, non-steroidal anti-inflammatory drugs to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases is usually with β blockers, calcium channel blockers, and antiepileptics. Even many nutraceutical preparations are helpful in migraine including riboflavin, vitamin b12. This review focuses on the newer agents available for treatment of migraine with some sight into their clinical trials.